Live Breaking News & Updates on Oculis Sa

Stay updated with breaking news from Oculis sa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Oculis announces publication and presentation of Phase 2 data showing topical OCS-01 improves macular thickness and visual acuity in patients with diabetic macular edema

Oculis announces publication and presentation of Phase 2 data showing topical OCS-01 improves macular thickness and visual acuity in patients with diabetic macular edema Positive Phase 2 data ....

France General , Esther Chan , Brigid Lee , Amber Fennell , Kostenloser Wertpapierhandel , Louie Anne Gauthier , Sylvia Cheung , Matthew Cole , Consilium Strategic Communications , Riad Sherif , Anne Gauthier , Strategic Marketing , Cindy Lung ,

Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease

Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease Positive Phase 2 data, published ....

France General , Brigid Lee , Amber Fennell , Ericb Papas , Louie Anne Gauthier , Sylvia Cheung , Matthew Cole , Esther Chan , Kostenloser Wertpapierhandel , Christophe Baudouin , National Ophthalmology Hospital , Eudeseuropean Dry Eye Society , Consilium Strategic Communications , Clinical Ophthalmology , Quinze Vingts National Ophthalmology Hospital , Dry Eye Disease , Oculis Ophthalmology Franchise , Riad Sherif , Anne Gauthier , Strategic Marketing , Cindy Lung , Eye Disease , Dry Eye Society , Eye Disease Landscape , Dry Eye So Difficult ,

Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics

Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics First-in-class peptidomimetic with distinct MoA ....

France General , Comunidad Autonoma De Cataluna , Brigid Lee , Amber Fennell , Nic Johnson , Matthew Cole , Allison Connolly , Laurent Nguyen , Emilie Chouinard , Esther Chan , Kostenloser Wertpapierhandel , Juliette Schmitt , Anthony Rosenberg , Jo Galatioto , Malta Life Sciences , Public University Hospital Group , University Of Barcelona , Centre For Technological , Industrial Development , Andrew Lloyd Associates , Alta Life Sciences Spain , Consilium Strategic Communications Europe , Oculisstrengthens Leading Ophthalmology Pipeline , In Licensing Neuroprotective Drug Candidate , Accure Therapeutics , Chief Executive Officer ,

Oculis appoints Dr. Bastian Dehmel as Chief Development

Oculis appoints Dr. Bastian Dehmel as Chief Development Officer Former Amgen Global Development Leader/OxThera CMO joins Oculis as Chief Development. ....

Brigid Lee , Amber Fennell , Louie Anne Gauthier , Sylvia Cheung , Bastian Dehmel , Matthew Cole , Allison Connolly , Esther Chan , Oculis Sa , Novo Nordisk , Consilium Strategic Communications Europe , Amgen Global Development Leader Oxthera , Chief Development , Chief Development Officer , New Drug Application , Chief Medical , Internal Medicine , Molecular Medicine , Chief Executive Officer , Riad Sherif , Anne Gauthier , Strategic Marketing , Cindy Lung , Strategic Communications , R Bastian Dehmel , Riad Sherif ,